Featured « AGORACOM Small-cap Investor Relations Blog

Archive for the ‘Featured’ Category

Else Nutrition $BABY.ca $BABYF Upgraded to OTCQX Best Market $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 8:56 AM on Friday, July 24th, 2020

http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Announced that its common shares have been approved for trading on the OTCQX® Best Market, a U.S. market operated by the OTC Markets Group
Else Nutrition’s shares were previously traded on the OTCQB® Venture Market
“We are very excited to have qualified to upgrade our US trading to the OTCQX Market,” commented Ms. Hamutal Yitzhak, Else Nutrition CEO and Co-Founder

VANCOUVER, BC, July 24, 2020 – Else Nutrition Holdings Inc. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”), is pleased to announce that its common shares have been approved for trading on the OTCQX® Best Market, a U.S. market operated by the OTC Markets Group. Else Nutrition’s shares were previously traded on the OTCQB® Venture Market.

“We are very excited to have qualified to upgrade our US trading to the OTCQX Market,” commented Ms. Hamutal Yitzhak, Else Nutrition CEO and Co-Founder. “We believe that trading on the OTCQX Market will further raise visibility of Else Nutrition in the US and international marketplace as well as enhance trading liquidity and expand our shareholder base.”

The OTCQX Market is designed for established, investor-focused companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. and international investors.

The Company also announces that its board of directors has approved on the issuance of incentive stock options (collectively, the “Options”) to a number of its directors, officers, employees and consultants to purchase up to a total of 1,462,250 common shares in the capital of the Company (each, a “Common Share”). Of such Options, an aggregate of 687,500 Options are allocated to the directors and officers. This is a normal-course option grant that comprises part of the long-term compensation and retention incentives provided by the Company.

Each Option is exercisable into one Common Share up to five years from the issuing date at a price of CND $2.19 per Common Share or in the case of 72,000 Options to be granted to a certain consultant, at the closing price of the Common Shares on TSX Venture Exchange on the date immediately preceding the effective Option grant. The grant of the Options is subject to approval from the TSX Venture Exchange and the terms and conditions of the Company’s shareholder approved 2019 Stock Option Plan.Else Nutrition shares also trade on the TSX Venture Exchange under the symbol BABY and on the Frankfurt Stock Exchange under the symbol 0YL.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

OTC Link ATS and OTC Link ECN are SEC regulated ATSs, operated by OTC Link LLC, member FINRA/SIPC.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among othersForward-looking statements made in this press release assume, among others, the timing of the Company’s toddler nutrition product launch and the availability of the Company’s product online. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Tags: baby food, CSE, investing, organic, small cap
Posted in All Recent Posts, Else Nutrition Holdings Inc., Featured | Comments Off on Else Nutrition $BABY.ca $BABYF Upgraded to OTCQX Best Market $KMB $BMY $ABT $WYE

Avicanna $AVCN.ca announces the award of two Canadian government NSERC grants: 1) Cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 in collaboration with the University of Toronto; and, 2) Evaluation of cannabinoids for reversing cannabis-based toxicosis in collaboration with the University of Guelph $CRDL.ca $PCLO.ca

Posted by AGORACOM-JC at 8:00 AM on Friday, July 24th, 2020

http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

– In addition to a recent MITACS award, Dr. Christine Allen, a Professor at the University of Toronto, was awarded an NSERC Alliance grant for development of cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 induced lung inflammation

– Avicanna further expands its existing neurobiological research collaboration with Dr. Jibran Khokhar, a Professor at the University of Guelph, with a 2-year NSERC Alliance grant to investigate the neural basis of cannabis-induced toxicosis

– The two NSERC grants leverage the proven track record of Avicanna, the University of Toronto and the University of Guelph in the research and clinical development of cannabinoid-based medicines

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/

TORONTO, July 24, 2020 – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that the Company’s research collaborators have received two independent peer-reviewed grants from the Natural Sciences and Engineering Research Council of Canada (“NSERC“). The NSERC Alliance grants will be used to expand the investigators’ collaborative research with Avicanna.

For the past three years, Dr. Christine Allen’s research group (CARG) in the Leslie Dan Faculty of Pharmacy at the University of Toronto has supported the development and optimization of Avicanna’s cannabinoid-based products including commercial cosmetics (Pura H&W) and medical cannabis (Rho Phyto) product lines and the pharmaceutical pipeline that is currently under clinical investigation. Dr. Allen will now leverage a recent MITACS award in addition to this NSERC Alliance grant in collaboration with Avicanna to develop a cannabinoid-based formulation for treatment of COVID-19 related lung inflammation.

A second NSERC Alliance grant was awarded to Dr. Jibran Khokhar, Assistant Professor at the University of Guelph, who has an extensive track-record in behavioural pharmacology and neuroscience. Avicanna’s research program with Dr. Khokhar focuses on evaluating a variety of cannabinoids in several preclinical models of human psychiatric conditions including mental health disorders such as anxiety, depression, and PTSD. The NSERC grant was awarded to evaluate the neurobiological underpinnings of cannabis toxicosis in a preclinical model, and test the potential efficacy of Avicanna’s naturally-derived cannabinoids and formulations in the treatment of cannabis-induced toxicosis. With the recent changes in the Canadian regulations for Cannabis 2.0 allowing for cannabinoid edibles and vapes, there is concern around an increased risk for adverse events arising from accidental high-dose cannabis ingestion. Thus, this two-year project will determine the behavioural and neural correlations of cannabis-induced toxicosis and the effects of cannabinoids for counteracting cannabis-induced toxicosis.

Dr Jibran Khokhar, commented, “This research is extremely timely with the new Cannabis 2.0 regulations and the increased risk for cannabis-induced toxicosis. I am thankful to NSERC and Avicanna for support of this important research that will have an impact in our understanding of the neurobiological underpinnings of, and provide novel treatment avenues to treat, adverse events related to high-dose cannabis exposures.”

About Avicanna Inc.

Avicanna is an Ontario, Canada based corporation focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products through its two main business segments, cultivation and research and development.

Avicanna’s two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna’s cultivation activities. These two companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including cannabidiol (CBD) and tetrahydrocannabinol (THC).

Avicanna’s research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna’s scientific team develops products, and Avicanna has also engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto for the purpose of optimizing and improving upon its products.

Avicanna’s research and development and cultivation activities are focused on the development of its key products, including plant-derived cannabinoid pharmaceuticals, phyto-therapeutics, derma-cosmetics, and Extracts (defined as plant-derived cannabinoid extracts and purified cannabinoids, including distillates and isolates), with a goal of eventually having these products manufactured and distributed through various markets.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the ability of the Company and CARG to develop cannabinoid-based pharmaceutical formulations to treat COVID-19 induced lung inflammation, the ability of the Company to develop cannabinoid-based pharmaceutical products, the results of the two-year project with the University of Guelph determining the behavioural and neural correlations of cannabis-induced toxicosis and the effect of cannabinoids to counteract cannabis-induced toxicosis. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE Avicanna Inc.

Tags: cannabinoids, CSE, Marijuana, Medical Cannabis by Shoppers, Rho Phyto, stocks
Posted in Avicanna Inc., Featured | Comments Off on Avicanna $AVCN.ca announces the award of two Canadian government NSERC grants: 1) Cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 in collaboration with the University of Toronto; and, 2) Evaluation of cannabinoids for reversing cannabis-based toxicosis in collaboration with the University of Guelph $CRDL.ca $PCLO.ca

Empower Clinics $CBDT.ca Reports Fiscal 2019 Results $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:19 AM on Friday, July 24th, 2020

– 15,920 patient visits generating total revenue of $2,031,581 or $0.02 per share, compared to 7,607 patient visits generating $1,091,386 or $0.02 per share for fiscal 2018.

VANCOUVER, BC /July 24, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(OTC PINK:EPWCF)(Frankfurt:8EC)(“Empower” or the “Company“) has filed today its audited consolidated financial statements and related management’s discussion and analysis, both of which are available at www.SEDAR.com. All financial information in this press release is reported in United States dollars, unless otherwise indicated.

“2019 is defined by profound change for our Company setting the stage for the ongoing transition to a growth-oriented health & wellness brand, with substantially improved operating controls and improved cost structure.” said Steven McAuley, Chairman and CEO. “As we look ahead navigating a global pandemic, we find ourselves thriving, hiring and seeing patients in record numbers, further supporting our diversification to broader wellness services.”

2019 Highlights

15,920 patient visits generating total revenue of $2,031,581 or $0.02 per share, compared to 7,607 patient visits generating $1,091,386 or $0.02 per share for fiscal 2018.

Net loss of $4,301,663 or $0.04 per share, compared to $3,789,918 or $0.06 per share for fiscal 2018, which was primarily driven by the recognition of goodwill and intangible asset impairment losses related to the Sun Valley acquisition which arose due to changes in Arizona licensing requirements.

Cash used in operating activities was $2,273,188 or $0.02 per share, compared to $2,835,711 or $0.04 per share for fiscal 2018.

Cash at December 31, 2019 of $179,153, compared to cash of $157,668 at December 31, 2018.

Recent Highlights Subsequent to Year End

Private Placement: April 2020 Empower Clinics closes private placement of $653,000 CAD to support growth initiatives.

Psychedelics Division: May 2020 Empower enters into a term sheet to acquire an interest in the global royalty rights of Dosed Movie, launches Dosed Wellness, a psychedelics brand, launches new dedicated website www.dosedwellness.com and adds new team members dedicated to the new brand.

COVID-19 Testing: April 2020 the Company launches a four-phase roll-out of COVID-19 testing in clinics and onsite for businesses.

Cannvas Education Platform: May 2020 Empower and EuroLife Brands complete definitive agreement for multi-year, multi-national licence of EurolIfe’s cannvas.me web-based education technology platform to deliver brand, product, and industry knowledge to the market.

Private Placement: July 2020 Empower Clinics closes private placement of $720,866 to support growth initiatives.

Financial Summary

Financial Performance

Clinic revenues for Q4 and full year 2019 were $542,677 and $1,949,549, respectively, compared to Q4 and full year 2018 revenues of $196,909 and $1,091,386, respectively. This increase above prior year is attributable to the acquisition of Sun Valley and the addition of 5 clinics which drove an increase in patient count from 7,607 in fiscal 2018 to 15,920 in fiscal 2019.

Direct clinic expenses for Q4 and full year 2019 were $615,814 and $826,276, respectively, compared to Q4 and full year 2018 direct clinic expenses of $115,655 and $417,047, respectively. This increase above prior year is attributable to the increase in number of patient visits.

Net loss from operations for Q4 and full year 2019 were $1,132,784 and $3,680,060, respectively, compared to Q4 and full year 2018 net loss of $592,899 and $4,309,373, respectively. This decrease below prior year is primarily attributable to the increase in net clinic revenues. While there was an increase in salaries and wages with the acquisition of Sun Valley, this increase was offset by a decline in share-based payments and legal and professional fees.

Net loss for Q4 and net loss for the full year 2019 were $1,942,084 and $4,301,663, respectively, compared to Q4 and full year 2018 net income of $1,342,930 and net loss of $3,789,918, respectively. This increase over prior year is primarily attributable to the recognition of goodwill and intangible asset impairment of $2,377,397 and $93,757, respectively. Partially offsetting these one-time expenses is an increase in the gain recognized on the warrant liability and conversion feature associated with the convertible debentures that resulted from the decrease in the Company’s share price and therefore the value of the warrants and convertible debentures exercisable.

During the year ended December 31, 2019, the Company used $2,273,188 in cash from operations after changes in non-cash working capital. The Company invested $3,828 towards property and equipment and raised $3,085,819 via proceeds from various issuances of shares, notes, and convertible debentures.

Please refer to the Company’s audited consolidated financial statements, related notes and accompanying Management Discussion and Analysis for a full review of the operations.

About Empower

Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.

ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer

CONTACTS:

Investors	Dustin Klein	Steven McAuley
	Director	CEO
	647-620-5101	604-789-2146
	[email protected]	[email protected]

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding the direction and growth prospects of the Company, the expansion of the company’s clinic and distribution network, the expected effect of the Vendors in their new roles with the Company, the effect on the lives of patients, the growth into a national brand, the effect of the Transaction, the diversification of the Company’s business model, the potential appeal to shareholders, the growth of the Company’s patient list and the effect thereof, the expected benefits for the company’s patient base and customers, the release of the cash consideration, the release of Shares being held in escrow in connection with the Transaction and statements regarding the Company’s proprietary product line “Sollievo”. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including that the Company may not be able to expand, that the Transaction may not have the expected results, and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Tags: CBD, CSE, Dosed Movie, Dosed Wellness, Hemp, tsx
Posted in Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Reports Fiscal 2019 Results $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

$KABN.ca Liquid Avatar to Join Apex Comics Group Presentation at Comic-Con @Home $MOS.ca $MOGO.ca $CTZ.ca $PTO.ca $PAY.ca

Posted by AGORACOM-JC at 4:15 PM on Thursday, July 23rd, 2020

This image has an empty alt attribute; its file name is image-3.png

Announced that on Saturday, July 25 at 5 pm Pacific / 8 pm Eastern, in conjunction with Apex Comics group CEO and Founder, Mariano Nicieza, KABN will be presenting a virtual discussion and overview of the Liquid Avatar platform (www.liquidavatar.com) at Comic-Con @ Home for comic book, fantasy, anime, manga and gaming fans worldwide
Event can be viewed at: https://comiccon2020.sched.com/event/d4zK/apex-comics-publishing-group-2020-2021-exclusive-previews
The Liquid Avatar platform allows for the management and control of digital identity as well as personal and private data and is available to consumers at no cost

TORONTO, CANADA / July 23, 2020 / KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN” or “KABN North America“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the US, is pleased to announce that on Saturday, July 25 at 5 pm Pacific / 8 pm Eastern, in conjunction with Apex Comics group CEO and Founder, Mariano Nicieza, KABN will be presenting a virtual discussion and overview of the Liquid Avatar platform (www.liquidavatar.com) at Comic-Con @ Home for comic book, fantasy, anime, manga and gaming fans worldwide. The event can be viewed at: https://comiccon2020.sched.com/event/d4zK/apex-comics-publishing-group-2020-2021-exclusive-previews. The Liquid Avatar platform allows for the management and control of digital identity as well as personal and private data and is available to consumers at no cost.

This event also begins the launch of Liquid Avatar’s Open Call for the Artist community, allowing students, emerging artists, hobbyists and others to create and provide submissions for review, by a panel of experts, for feedback and potential inclusion into the Liquid Avatar Marketplace (“Marketplace”) coming later this summer. All approved Artists will have their own catalog presented in the Marketplace allowing them to showcase icons available for sale.

The Liquid Avatar Marketplace will offer users with a new type of Avatar experience in addition to their free icons that they can create in the platform’s Creative Studio. Liquid Avatar users will be able to acquire custom-designed and limited availability icons from leading pop culture, comic book, fantasy, manga, and contemporary Artists complete with an innovative digital authentication solution that has been traditionally managed as an on-site, personnel and location-based process. All Liquid Avatars acquired from the Marketplace will be supported with a unique Digital Certificate of Authenticity, allowing each custom icon to have its own Blockchain identifier that can be transferred from one user to another.

“The reaction from the professional Artist and Creator community has been outstanding and we’ve already received submissions of some great icons for the Liquid Avatar Marketplace,” said Mariano Nicieza, CEO and Founder Apex Comics Group. “By opening the program to the overall market and allowing other talented Artists to come forward and participate and create icons, I believe, will further enhance the opportunities for Liquid Avatar.”

Liquid Avatar has begun its North American launch program to early adopters and welcomes the public to request an invitation at: https://liquidavatar.com/liquid-avatar-early-adopter/

About KABN North America – www.kabnnaholdco.com

KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from its use of their online identity. KABN propriety technology suite includes 4 key products:

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allows users to use Liquid Avatars to share public and permission based private data when they want and with whom they want. www.liquidavatar.com

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives. www.kabncard.com

KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.

KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com

KABN Systems NA Holdings Corp. is publicly traded on the Canadian Securities Exchange under the symbol: KABN

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

For further information, please contact:

Ben Kessler
Chief Executive Officer
647-725-7742 Ext. 700
[email protected]

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Tags: blockchain, canadian fintech, crypto, CSE, Liquid Avatars, tsx, tsx-v
Posted in Featured, KABN, KABN Systems NA Holdings Corp. | Comments Off on $KABN.ca Liquid Avatar to Join Apex Comics Group Presentation at Comic-Con @Home $MOS.ca $MOGO.ca $CTZ.ca $PTO.ca $PAY.ca

PyroGenesis $PYR.ca Confirms Total Receipts of over $7.5MM in Payments Under $25M+ DROSRITE Contract $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 3:18 PM on Thursday, July 23rd, 2020

Confirmed today that in response to additional inquiries with respect to the subject matter, payments totaling over $7.5MM have been received to date under the exclusive contract with Drosrite International LLC
“We decided to, once again, confirm the total payments received to date under the $25MM+ DROSRITE™ contract due to a large number of inquiries received from shareholders and investors,” said Mr. P. Peter Pascali, President and CEO of PyroGenesis.

MONTREAL, July 23, 2020 — PyroGenesis Canada Inc. (http://www.pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to confirm today that, in response to additional inquiries with respect to the subject matter, payments totaling over $7.5MM have been received to date under the exclusive contract with Drosrite International LLC (“DI”).

“We decided to, once again, confirm the total payments received to date under the $25MM+ DROSRITE™ contract due to a large number of inquiries received from shareholders and investors,” said Mr. P. Peter Pascali, President and CEO of PyroGenesis. “It should also be noted that an additional payment of over $2.5MM is expected in the next few weeks. All these payments are being made based on previously agreed to milestones and all are being paid on time. In fact, none of our contracts have been materially affected by COVID-19 and are all progressing as expected.”

About Drosrite International LLC

DI is a US based private company duly constituted and existing under the laws of the State of Delaware, providing state-of-the-art waste management technologies to the aluminum industry. DI is duly licensed by PyroGenesis to manufacture, market, sell and distribute DROSRITE™ systems and technology to the Kingdom of Saudi Arabia, and certain other countries in the Middle East, on an exclusive basis. All DROSRITE™ systems supplied by DI are manufactured in the USA.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:

Rodayna Kafal, Vice President Investors Relations and Strategic Business Development,
Phone: (514) 937-0002, E-mail: [email protected]

RELATED LINK: http://www.pyrogenesis.com/

Tags: drosrite, plasma, powders, PUREVAP, PyroGenesis, small cap investment, tsx, tsx-v
Posted in All Recent Posts, Featured, PyroGenesis Canada Inc. | Comments Off on PyroGenesis $PYR.ca Confirms Total Receipts of over $7.5MM in Payments Under $25M+ DROSRITE Contract $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Loop Insights $MTRX.ca Launches Contact Tracing Platform in Las Vegas with Global Hospitality Company $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 7:15 AM on Thursday, July 23rd, 2020

Announced the launch of its contact tracing platform in Nevada with two of Grupo Anderson’s flagship restaurants in Las Vegas, Senor Frog’s and Carlos’n Charlies
Loop’s contact tracing solution entry into Las Vegas, with a globally recognized hospitality company, supports the Company’s broader goals for global adoption
In addition to possible expansion into Grupo Anderson’s other locations in tourist destinations such as Mexico, the Caribbean, and Spain, Loop is also gaining traction with large-scale projects in Canada, Australia, the UK, and Indonesia

VANCOUVER, BC, July 23, 2020 – Loop Insights Inc. (TSXV: MTRX) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive marketing and real-time consumer insights, is pleased to announce the launch of its contact tracing platform in Nevada with two of Grupo Anderson’s flagship restaurants in Las Vegas, Senor Frog’s and Carlos’n Charlies.

NEVADA ENTRY SUPPORTS GLOBAL ADOPTION GOALS

Loop’s contact tracing solution entry into Las Vegas, with a globally recognized hospitality company, supports the Company’s broader goals for global adoption. In addition to possible expansion into Grupo Anderson’s other locations in tourist destinations such as Mexico, the Caribbean, and Spain, Loop is also gaining traction with large-scale projects in Canada, Australia, the UK, and Indonesia.

Loop Insights CEO, Rob Anson stated: Las Vegas is a clear global leader in critical billion-dollar industries related to hospitality, gaming, sports & entertainment, and tourism. During these uncertain times, companies and cities around the world are looking to Las Vegas for direction on solutions; it is a major priority for Loop to help these Nevada industries and demonstrate to the world what is possible. Our discussions with casino operators, conference centers, university campuses, stadium operators, and professional sports teams are now being fast tracked because our automated contact tracing solution is highly adoptable, easy to use, accurate, secure, and can connect with other Covid-19 technology. Launching with recognizable brands, such as Senor Frog’s and Carlos’n Charlies, secures our leadership position in moving forward with other Las Vegas venues.

Senor Frog’s USA Director of Operations, Omar Licon Schmitt stated: Covid-19 certainly threw Las Vegas a curveball, and all industries need to pivot to both reopen and remain open. Adopting proper safety measures is a top priority for all in order to ensure both staff and customers to feel safe. Loop’s ability to securely capture names and phone numbers with one tap of the mobile device is impressive and something we haven’t seen on the market to date. We see this automated solution being adopted Vegas-wide, and we look forward to building a safe community together.

LAS VEGAS NEEDS TO PROTECT INDUSTRIES FROM 2ND WAVE OF COVID-19

The Company is accelerating opportunities to implement its contact tracing platform in Las Vegas as a sense of urgency grows to protect its billion-dollar industries and economy. Loop’s solution integrates its Fobi technology with mobile wallet pass technology to create a platform that is proven, reliable, and highly scalable to support large adoption rates on any existing infrastructure.

Government officials and business owners are aware that a second wave is a major potential threat. Implementing best practice protocols will help instill confidence, keep all stakeholders safe, and ensure Las Vegas remains open and revive its economy.

The scope of opportunity to keep people safe and businesses open is massive, as Las Vegas hosts just under 50 million visitors and generates 58 billion dollars in annual tourism alone. With tourism and other revenue-generating industries being closed for most of the year to date, time is of the essence. Loop’s speed to scale supports accelerated revenue streams for the Company, including onboarding fees per location, monthly Software as a Service fees, and active user fees.

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion and Q&A https://agoracom.com/ir/LoopInsights/forums/discussion

About Grupo Anderson’s: Founded in 1963 and based in Cancun, Grupo Anderson’s has developed several restaurant concepts including Carlos’n Charlie’s, Senor Frog’s, Carlos O’Brian’s and El Squid Roe. The company has restaurants in Mexico, South America, the Caribbean, Spain, and, most recently, the United States.

About Loop Insights: Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.

Forward-Looking Statements/Information:

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE LOOP Insights Inc.

Tags: AI, covid19, Covid19 tracing, internet of things, IOT, stocks, tsx
Posted in Featured, Loop Insights Inc. | Comments Off on Loop Insights $MTRX.ca Launches Contact Tracing Platform in Las Vegas with Global Hospitality Company $QUIS.ca $MCLD.ca $NXO.ca

VIDEO – Loop Insights $MTRX.ca Artificial Intelligence #AI + ImagineAR $IP.ca $IPNFF Augmented Reality Will Change Shopping Forever $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 9:00 PM on Wednesday, July 22nd, 2020

“Change Shopping Forever” … that’s a pretty bold statement to make from two small cap companies in the early stages of commercialization. But when you watch this interview, it becomes pretty apparent why Loop Insights (MTRX:TSXV) and ImagineAR (IP:CSE / IPNFF:OTCQB) realized within a couple of hours of speaking they were creating the “Minority Report” of shopping.

How?

Well, this is the part where we write a carefully crafted synopsis of the interview to provide viewers with enough context to dive into the video. But this is the first time in our existence where a synopsis just isn’t possible because it’s tough enough trying to describe the benefits of one paradigm shifting technology, let alone two of them that have joined forces. If we tried, we’d give away the entire interview and still not do it justice.

Trust us that this is a video you have to watch – and then share. In fact, you’ll probably end up watching it a couple of times.

These two companies are onto something we’ve never seen before. At Agoracom, we believe the convergence of AI and AR is going to change the world this decade in many applications – and we just found the first two companies who may very well be doing by closing the loop between E-commerce and Bricks & Mortar.

Get your popcorn ready.

Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.

Tags: AI, AR, augmented reality, covid19, Covid19 tracing, internet of things, IOT, stocks, tsx, tsx-v
Posted in AGORACOM Via Satellite, Featured, Imagine AR, Loop Insights Inc. | Comments Off on VIDEO – Loop Insights $MTRX.ca Artificial Intelligence #AI + ImagineAR $IP.ca $IPNFF Augmented Reality Will Change Shopping Forever $SEV.ca $VST.ca $YDX.ca $NTAR.ca

TransCanna $TCAN.ca Seizes New Processing Opportunity and Expands Operations at Daly Street Building $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 4:15 PM on Wednesday, July 22nd, 2020

Announced that Lyfted Farms Inc. (a wholly-owned subsidiary) will build a processing division inside its Daly Street Building
Aas not originally planned in phase one in order to meet the increased demand for this service and ultimately increase profits margins
Once operational, the division will oversee the trimming, drying, curing, grading and packaging of cannabis, and support TransCanna’s strategy of vertical integration of the California cannabis market through distribution centers serving Northern California from the Daly Street building, and Southern California from the Company’s recently announced Lemoore facility

Vancouver, British Columbia–(July 22, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) TransCanna announces that Lyfted Farms Inc. (a wholly-owned subsidiary) will build a processing division inside its Daly Street Building that was not originally planned in phase one in order to meet the increased demand for this service and ultimately increase profits margins.

Once operational, the division will oversee the trimming, drying, curing, grading and packaging of cannabis, and support TransCanna’s strategy of vertical integration of the California cannabis market through distribution centers serving Northern California from the Daly Street building, and Southern California from the Company’s recently announced Lemoore facility.

“Once we received our final State License for the Daly Building, our already existing demand increased significantly. To meet this demand and seize the opportunity we saw to really drive our bottom line margin through processing, we sped up the timeline to add processing at this level,” said Bob Blink, TransCanna CEO. “We have the team and the space to execute this. Being agile enough to adapt to a changing market and identify opportunities for growth within it speaks to our collective mindset. When we run the numbers, we can see upon execution this service adding an additional 10% to our forecasted revenue targets,” adds Blink.

“This will facilitate the larger strategy of the Daly facility becoming a central distribution point for Lyfted Branded products and a wholesale processing center,” said Alan Applonie, company General Manager. “Converging marketing and buying interests into a single Northern California location gives state-wide buyers a broader range of products to purchase,” he adds.

The Processor License is an additional license type not included in the original statute specifically added for processors. As this is a new business segment whilst being built out, the Company has submitted an application for a Processor License and anticipates approximately a 90-day timeline to receive it.

The Daly building’s phase one deployment plan will also accommodate perpetual storage of at least 20,000 lbs. of cannabis flower in a climate-controlled atmosphere that will serve business-to-business cannabis market demand throughout California.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed, Company building cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors
Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of the Company. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements referred to herein as “forward-looking statements”, are not historical facts, are made as of the date of this news release and include without limitation estimates and forecasts and statements as to management’s expectations for growth and the commencement of operations of the Company’s Daly facility.

The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including that operations will commence at the Company’s Daly facility in Modesto, California, as and when expected.

These forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially from any future results, events or developments expressed or implied by such forward-looking statements. Risks and uncertainties associated with the forward-looking information in this news release include, among others, dependence on obtaining and maintaining regulatory approvals, including state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete upgrades to its Daly facility in a timely manner; engaging in activities which currently are illegal under U.S. federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth;; reliance on management; and the effect of capital market conditions and other factors (including those related to the COVID-19 pandemic) on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look, except in accordance with applicable securities laws.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN

Tags: california cannabis, Cannabis, CBD, CSE, Hemp, Marijuana, small cap, small cap stocks
Posted in Featured, TransCanna Holdings Inc. | Comments Off on TransCanna $TCAN.ca Seizes New Processing Opportunity and Expands Operations at Daly Street Building $CGC $ACB $APH $CRON.ca $OGI.ca

#Platinum and #palladium will creep higher as auto sector returns to life SPONSOR: New Age Metals $NAM.ca $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 12:35 PM on Tuesday, July 21st, 2020

SPONSOR: New Age Metals Inc. The company owns one of North America’s largest primary platinum group metals deposits in Sudbury, Canada. The company has an updated NI 43-101 Mineral Resource Estimate of 2,867,000 PdEq Measured and Indicated Ounces, with an additional 1,059,000 PdEq Ounces Inferred. Learn More.

Platinum and palladium will creep higher as auto sector returns to life

Palladium – which cost around $2,070 an ounce on Tuesday – will average $2,050 this year and $2,138 in 2021, according to the median result from a poll of 32 analysts and traders.
A similar poll in April forecast averages of $2,100 this year and $2,150 in 2021.
Platinum – currently around $840 an ounce – will average $832 this year and $913 in 2021. The poll three months ago predicted averages of $836 an ounce for 2020 and $945 for 2021.

By: Sumita Layek and Peter Hobson

LONDON — Analysts and traders have cut their forecasts for autocatalyst metals platinum and palladium as the coronavirus outbreak curtails vehicle sales, but they still expect prices for both to rise gradually through 2021, a Reuters poll showed.

Platinum and palladium are used mainly in engine exhausts to reduce emissions. Platinum is also used in jewelry.

Years of undersupply pushed palladium to record highs above $2,800 an ounce this year, while surpluses have kept platinum near multi-year lows.

Prices plunged in March as the coronavirus choked economic activity but have since recouped some ground as China rebounds.

Palladium – which cost around $2,070 an ounce on Tuesday – will average $2,050 this year and $2,138 in 2021, according to the median result from a poll of 32 analysts and traders.

A similar poll in April forecast averages of $2,100 this year and $2,150 in 2021.

Platinum – currently around $840 an ounce – will average $832 this year and $913 in 2021. The poll three months ago predicted averages of $836 an ounce for 2020 and $945 for 2021.

Palladium is likely to remain in deficit while platinum will be oversupplied, analysts said.

“Auto sector recovery is key for platinum prices, as we doubt jewelry demand will see any revival this year,” said ANZ analyst Soni Kumari.

“The market is flipping from a deficit in 2019 into a surplus of 480,000-500,000 ounces in 2020.”

Palladium use in China has remained solid and there could be a pick-up in speculative buying, which has remained very low, said VTB Capital analyst Dmitry Glushakov.

(Reporting by Peter Hobson and Sumita Layek; editing by Pratima Desai and Susan Fenton)

Source: https://financialpost.com/pmn/business-pmn/platinum-and-palladium-will-creep-higher-as-auto-sector-returns-to-life

Tags: CSE, palladium, PGM, PGM Demand, Pine Zone
Posted in Featured, New Age Metals | Comments Off on #Platinum and #palladium will creep higher as auto sector returns to life SPONSOR: New Age Metals $NAM.ca $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

TransCanna $TCAN.ca and Award-Winning Product Producers, the Summit Boys, to Co-Brand #Cannabis Concentrates $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:11 AM on Tuesday, July 21st, 2020

Announced a Memorandum of Understanding with award-winning and leading legacy cannabis brand, the Summit Boys, to co-brand a series of high-quality cannabis concentrates
Summit Boys are a well-known legacy recreational cannabis product producers (operating since 2016 under prop 215 and with a cult-like following on Instagram of over 66,000 followers).
Demand for Cannabis Concentrates are the Fastest Growing of all Related Product Categories

Vancouver, British Columbia–(July 21, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce a Memorandum of Understanding with award-winning and leading legacy cannabis brand, the Summit Boys, to co-brand a series of high-quality cannabis concentrates.

The Summit Boys are a well-known legacy recreational cannabis product producers (operating since 2016 under prop 215 and with a cult-like following on Instagram of over 66,000 followers). In this agreement, Lyfted Farms (a TransCanna subsidiary), will supply high-quality cannabis flower to the Summit Boys for processing into a line of popular cannabis concentrates branded as ‘Caviar.’

In 2019, the Summit Boys earned 14 awards in the Bay Area Cannabis Cup in several categories, including for Best Product and Hybrid Concentrate for this same Caviar product. The line of ‘White Caviar’ branded products are what The Summit Boys are best known for.

Cannabis concentrates have a greater proportion of cannabinoids and terpenes when compared to natural cannabis flowers, and can increase the potency of cannabis flower. Demand for these concentrates are also the fastest-growing of any cannabis product in the California market (the largest Cannabis market globally).

“This co-branding of the already famous Caviar product now powered by Lyfted’s flower is great news for cannabis consumers,” says Bob Blink, TransCanna CEO. “For us, it’s another example of our strategy to align with high-quality producers and already successful players in the industry-this time with the added value of the Summit Boys’ grassroots following. But for the more sophisticated California cannabis market, this partnership will mean an even higher quality product for consumers.”

“As a dedicated brand to California Cannabis market, we wanted to find like-minded partners. Since meeting the Lyfted team, they have earned our respect, and we definitely look forward to working together. There are many things that excite us, but being able to co-brand and scale now that the Daly Facility is licensed is a huge opportunity, ” stated Mike Larson, Summit Boys CEO.

News of this agreement follows an announcement by TransCanna that the Company was awarded its final operating license for the 196,000 square foot Daly Facility by the California Bureau of Cannabis Control July 10, 2020.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors,

Bob Blink, CEO
604-349-3011

Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of the Company. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements, referred to herein as “forward-looking statements”, are not historical facts, are made as of the date of this news release and include without limitation estimates and forecasts and statements as to management’s expectations for growth and the commencement of operations of the Company’s Daly facility.

Tags: california cannabis, Cannabis, CBD, CSE, Hemp, Marijuana, small cap, small cap stocks, tsx
Posted in Featured, TransCanna Holdings Inc. | Comments Off on TransCanna $TCAN.ca and Award-Winning Product Producers, the Summit Boys, to Co-Brand #Cannabis Concentrates $CGC $ACB $APH $CRON.ca $OGI.ca

Archive for the ‘Featured’ Category

Categories